Search This Blog

Thursday, August 1, 2019

Emergent Biosolutions EPS beats by $0.03, beats on revenue

Emergent Biosolutions (NYSE:EBS): Q2 Non-GAAP EPS of -$0.12 beats by $0.03; GAAP EPS of -$0.18 misses by $0.03.
Revenue of $243.2M (+10.4% Y/Y) beats by $25.26M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)